Skip to main content
. 2015 Jun 11;12(8):2912–2923. doi: 10.1021/acs.molpharmaceut.5b00173

Table 3. On-Target AUC, off-Target AUC, and DTI of Tylocrebrine.

  free drug nontargeted nanoparticles targeted nanoparticles
AUCtumor (μg h mL–1) 5.5 6.8 17.7
AUCbrain (μg h mL–1) 2.1 1.0 1.3
DTI   2.6 5.2